Archives big-pharma

Entry Author Date Location
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
SQZ Biotech Shifts to Therapy Development with $5M Series A 06/24/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
As Pharma Collaborations Gain Importance, GSK Opens Second Outpost 03/27/15 San Diego
Arrowhead’s Novartis RNAi Deal: Big Boost or ‘Stale Potato Chips’? 03/09/15 Wisconsin
Unchained Labs Grabs $25M and New Device to Test Stability of Proteins 02/12/15 San Francisco
Why Boston Biotech Should Look to London 02/09/15 Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
Vertex Stock Up 40 Percent After Cystic Fibrosis Trial Results 06/24/14 Boston
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
Balancing Power Between Biotech and Big Pharma Benefits Both 02/19/14 San Diego
Texas Biotech Leaders Doubt CPRIT Will Get Its Groove Back 01/24/14 Texas
Janssen Tests Ideas, Apps, in Bid for Clinical Trials Innovation 01/08/14 San Diego
Glaxo Setting Up San Diego Outpost to Oversee its Westward Expansion 11/25/13 San Diego
Avalon Ventures’ $495M Deal Grew from GSK Quest for Academic Inroads 04/24/13 San Diego
GlaxoSmithKline and Avalon Ventures Agree to Startup Collaboration 04/22/13 San Diego
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
Janssen Forms “Investigator Databank” to Help Streamline Drug Trials 11/15/12 San Diego
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup 08/03/12 Boston
NJ Shocker: Roche to Shutter Nutley R&D Site 06/26/12 New York
Boston Business Leaders Reflect on Susan Hockfield’s MIT Presidency 02/16/12 Boston
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare 05/20/11 New York
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit 05/12/11 New York
FDA Panel Meets Today on Vertex HepC Drug 04/28/11 Boston
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
Page 1 of 3 next page »